<DOC>
	<DOCNO>NCT02988141</DOCNO>
	<brief_summary>A Prospective Multi-center Study Investigate EGFR-TKI Resistance Profile Chinese Patients Advanced EGFRm+ NSCLC</brief_summary>
	<brief_title>EGFR-TKI Resistance Profile Chinese Patients With Advanced EGFRm+ NSCLC</brief_title>
	<detailed_description>Patients EGFR mutation present secondary resistance prior first-generation EGFR-TKI receive biopsy least progressed lesion able provide tissue pathological examination NGS testing.All enrol patient follow clinical outcome ( treatment , tumor response , survival , etc ) .</detailed_description>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Provision inform consent prior study specific procedure . Male female patient age 18 year old . Histological confirmation stage IIIB/IV NSCLC . Documented EGFR mutation positive . WHO Performance Status 0 , 1 2 Any significant clinical disorder laboratory find make undesirable patient participate study . Previous ( within 6 month ) current treatment AZD9291 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>